These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

449 related items for PubMed ID: 26779870

  • 1. Causes of hypogonadotropic hypogonadism predict response to gonadotropin substitution in adults.
    Rohayem J, Sinthofen N, Nieschlag E, Kliesch S, Zitzmann M.
    Andrology; 2016 Jan; 4(1):87-94. PubMed ID: 26779870
    [Abstract] [Full Text] [Related]

  • 2. Testicular growth and spermatogenesis: new goals for pubertal hormone replacement in boys with hypogonadotropic hypogonadism? -a multicentre prospective study of hCG/rFSH treatment outcomes during adolescence.
    Rohayem J, Hauffa BP, Zacharin M, Kliesch S, Zitzmann M, “German Adolescent Hypogonadotropic Hypogonadism Study Group”.
    Clin Endocrinol (Oxf); 2017 Jan; 86(1):75-87. PubMed ID: 27467188
    [Abstract] [Full Text] [Related]

  • 3. Gonadotropin Treatment for the Male Hypogonadotropic Hypogonadism.
    Boeri L, Capogrosso P, Salonia A.
    Curr Pharm Des; 2021 Jan; 27(24):2775-2783. PubMed ID: 32445446
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Treatment of gonadotropin-deficient boys with recombinant human FSH: long-term observation and outcome.
    Raivio T, Wikström AM, Dunkel L.
    Eur J Endocrinol; 2007 Jan; 156(1):105-11. PubMed ID: 17218732
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Application of hormonal treatment in hypogonadotropic hypogonadism: more than ten years experience.
    Yang L, Zhang SX, Dong Q, Xiong ZB, Li X.
    Int Urol Nephrol; 2012 Apr; 44(2):393-9. PubMed ID: 21989858
    [Abstract] [Full Text] [Related]

  • 8. Evaluation of gonadotropin-replacement therapy in male patients with hypogonadotropic hypogonadism.
    Ortac M, Hidir M, Salabas E, Boyuk A, Bese C, Pazir Y, Kadioglu A.
    Asian J Androl; 2019 Apr; 21(6):623-627. PubMed ID: 31062720
    [Abstract] [Full Text] [Related]

  • 9. Seminal anti-Müllerian hormone level is a marker of spermatogenic response during long-term gonadotropin therapy in male hypogonadotropic hypogonadism.
    Sinisi AA, Esposito D, Maione L, Quinto MC, Visconti D, De Bellis A, Bellastella A, Conzo G, Bellastella G.
    Hum Reprod; 2008 May; 23(5):1029-34. PubMed ID: 18343809
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Gonadotropin treatment for male partial congenital hypogonadotropic hypogonadism in Chinese patients.
    Hao M, Nie M, Yu BQ, Gao YJ, Wang X, Ma WL, Huang QB, Zhang R, Mao JF, Wu XY.
    Asian J Androl; 2020 May; 22(4):390-395. PubMed ID: 31464203
    [Abstract] [Full Text] [Related]

  • 13. Pulsatile GnRH or human chorionic gonadotropin/human menopausal gonadotropin as effective treatment for men with hypogonadotropic hypogonadism: a review of 42 cases.
    Büchter D, Behre HM, Kliesch S, Nieschlag E.
    Eur J Endocrinol; 1998 Sep; 139(3):298-303. PubMed ID: 9758439
    [Abstract] [Full Text] [Related]

  • 14. Insulin-like peptide 3 (INSL3) in men with congenital hypogonadotropic hypogonadism/Kallmann syndrome and effects of different modalities of hormonal treatment: a single-center study of 281 patients.
    Trabado S, Maione L, Bry-Gauillard H, Affres H, Salenave S, Sarfati J, Bouvattier C, Delemer B, Chanson P, Le Bouc Y, Brailly-Tabard S, Young J.
    J Clin Endocrinol Metab; 2014 Feb; 99(2):E268-75. PubMed ID: 24243640
    [Abstract] [Full Text] [Related]

  • 15. A combined analysis of data to identify predictive factors for spermatogenesis in men with hypogonadotropic hypogonadism treated with recombinant human follicle-stimulating hormone and human chorionic gonadotropin.
    Warne DW, Decosterd G, Okada H, Yano Y, Koide N, Howles CM.
    Fertil Steril; 2009 Aug; 92(2):594-604. PubMed ID: 18930225
    [Abstract] [Full Text] [Related]

  • 16. Pulsatile GnRH Is Superior to hCG in Therapeutic Efficacy in Adolescent Boys With Hypogonadotropic Hypogonadodism.
    Gong C, Liu Y, Qin M, Wu D, Wang X.
    J Clin Endocrinol Metab; 2015 Jul; 100(7):2793-9. PubMed ID: 25978110
    [Abstract] [Full Text] [Related]

  • 17. Outcome of gonadotropin therapy for male hypogonadotropic hypogonadism at university affiliated male infertility centers: a 30-year retrospective study.
    Miyagawa Y, Tsujimura A, Matsumiya K, Takao T, Tohda A, Koga M, Takeyama M, Fujioka H, Takada S, Koide T, Okuyama A.
    J Urol; 2005 Jun; 173(6):2072-5. PubMed ID: 15879837
    [Abstract] [Full Text] [Related]

  • 18. Pulsatile gonadotropin-releasing hormone therapy is associated with earlier spermatogenesis compared to combined gonadotropin therapy in patients with congenital hypogonadotropic hypogonadism.
    Mao JF, Liu ZX, Nie M, Wang X, Xu HL, Huang BK, Zheng JJ, Min L, Kaiser UB, Wu XY.
    Asian J Androl; 2017 Jun; 19(6):680-685. PubMed ID: 28051040
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 23.